NCT00110435View on ClinicalTrials.gov

A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077)

PHASE3CompletedINTERVENTIONAL

Enrollment

1,229

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions

Type 2 Diabetes MellitusHypercholesterolemia

Interventions

DRUG

MK0653A, ezetimibe (+) simvastatin

DRUG

Duration of Treatment: 4 wk placebo run in then 6 wk active

DRUG

Comparator: atorvastatin

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00110435 - A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077) | Biotech Hunter | Biotech Hunter